×

Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists

  • US 20110136865A1
  • Filed: 09/30/2010
  • Published: 06/09/2011
  • Est. Priority Date: 12/02/2003
  • Status: Abandoned Application
First Claim
Patent Images

1. Use of pipamperon for the preparation of a medicament for treating a disease or disorder with an underlying dysregulation of the emotional functionality, wherein said pipamperon is administered to a patient in a dose ranging between 5 and 15 mg of the active ingredient, and wherein a second compound is administered simultaneously with, separate from or sequential to said pipamperon to augment the therapeutic effect of said second compound.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×